DaVita Inc. (NYSE:DVA) Receives Average Rating of "Hold" from Analysts

Shares of DaVita Inc. (NYSE:DVA - Get Free Report) have received an average recommendation of "Hold" from the six research firms that are presently covering the stock, Marketbeat.com reports. One research analyst has rated the stock with a sell recommendation, four have assigned a hold recommendation and one has assigned a buy recommendation to the company. The average 1-year target price among brokerages that have issued ratings on the stock in the last year is $164.50.

A number of equities research analysts recently issued reports on DVA shares. Truist Financial reduced their price target on DaVita from $170.00 to $164.00 and set a "hold" rating on the stock in a research report on Monday, May 19th. Wall Street Zen raised DaVita from a "hold" rating to a "buy" rating in a research report on Friday, April 25th.

DaVita Stock Performance

Shares of NYSE DVA traded up $0.59 during trading hours on Monday, reaching $140.95. 949,260 shares of the stock were exchanged, compared to its average volume of 804,289. The firm has a market capitalization of $10.64 billion, a price-to-earnings ratio of 13.97, a P/E/G ratio of 0.97 and a beta of 1.11. The company has a debt-to-equity ratio of 23.18, a quick ratio of 1.20 and a current ratio of 1.25. DaVita has a 52 week low of $131.76 and a 52 week high of $179.60. The stock's fifty day simple moving average is $139.43 and its 200 day simple moving average is $149.61.

DaVita (NYSE:DVA - Get Free Report) last announced its earnings results on Monday, May 12th. The company reported $2.00 earnings per share for the quarter, topping analysts' consensus estimates of $1.75 by $0.25. The company had revenue of $3.22 billion for the quarter, compared to analyst estimates of $3.22 billion. DaVita had a return on equity of 176.11% and a net margin of 6.63%. The firm's quarterly revenue was up 5.0% compared to the same quarter last year. During the same quarter last year, the company earned $2.26 earnings per share. Sell-side analysts predict that DaVita will post 10.76 EPS for the current year.

Institutional Investors Weigh In On DaVita

Large investors have recently modified their holdings of the business. UMB Bank n.a. boosted its holdings in shares of DaVita by 65.5% in the 1st quarter. UMB Bank n.a. now owns 192 shares of the company's stock valued at $29,000 after purchasing an additional 76 shares in the last quarter. National Pension Service boosted its holdings in shares of DaVita by 74.3% in the 1st quarter. National Pension Service now owns 197 shares of the company's stock valued at $30,000 after purchasing an additional 84 shares in the last quarter. Copia Wealth Management acquired a new stake in shares of DaVita in the 4th quarter valued at $30,000. Y.D. More Investments Ltd acquired a new stake in shares of DaVita in the 1st quarter valued at $35,000. Finally, SBI Securities Co. Ltd. acquired a new stake in shares of DaVita in the 4th quarter valued at $41,000. Institutional investors and hedge funds own 90.12% of the company's stock.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.